PM360 Lists TrialScope Engage™ Embedded
Among Most Innovative Healthcare Products of 2019
Technology integrates a robust clinical trial search function into a sponsor’s existing website
Jersey City, NJ, Dec. 13, 2019 — For the second year in a row, TrialScope, the global leader in clinical trial transparency, disclosure compliance and patient engagement technology solutions, has been recognized by PM360 for its forward-thinking innovation. PM360, a top trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, selected TrialScope Engage™ Embedded technology as one of the most innovative products of the year.
When deployed as part of a sponsor’s existing corporate website, TrialScope Engage Embedded is designed to improve patient engagement and increase trial transparency by connecting sponsors with patients, healthcare professionals, researchers and the public. Based on TransCelerate's Registry of the Future (ROTF) customer insights, the intuitive trial finder extracts vetted trial data from ClinicalTrials.gov automatically, and each trial detail page includes an interactive map enabling patients to pinpoint recruiting sites nearby. For sponsors looking to improve patient engagement and access to trials without the development of a standalone clinical trials website, TrialScope Engage Embedded shortens the implementation timeframe and minimizes the need for internal resources. The TrialScope Engage platform also includes a fully standalone version that works independently of a sponsor’s corporate website to deliver trial-related education in addition to an intuitive trial finder.
“TrialScope Engage Embedded is yet another example of our continuing innovation, our passion about easing the patient journey and our commitment to making our products and services scalable,” said TrialScope CEO Jeff Kozloff. “Just as we help sponsors make their clinical trials accessible to all patients, we work to make our technology accessible to all sponsors, large and small.
“We are truly honored to be recognized by PM360 for the second year in a row. We believe that trial transparency and patient engagement go hand in hand. In doing so, we are helping transform the industry mindset as many sponsors now see transparency not just as a regulatory requirement but as a strategic advantage.”
PM360 received hundreds of nominations from across the healthcare and life sciences industries in the categories of companies, startups, divisions, products, services and strategies. The PM360 editorial staff evaluated the submissions, and the most innovative — regardless of category — were selected.
“Innovation is one of the keys to success in any industry, but it doesn’t come without real effort,” says Anna Stashower, CEO/Publisher of PM360. “This year’s issue continues that tradition and provides our industry with a look at the latest offerings, services, ideas, and strategies in the industry that are helping to push healthcare and life sciences forward — and make it easier to better serve all healthcare stakeholders.”
The picks are published in the 8th edition of PM360’s Annual Innovations Issue, which was established to provide a comprehensive overview of the latest advancements within healthcare and life sciences, and offers brief profiles of each compelling innovation selected. TrialScope's profile can be found online at PM360.
For more information on TrialScope or its TrialScope Engage™ technology, visit TrialScope.com.
TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 16 of the top 20 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit TrialScope.com.